AUG 30, 2015 12:28 PM PDT

Cluttered Cellular Highways

WRITTEN BY: Ilene Schneider
Johns Hopkins researchers think that a common gene mutation triggers the brain damage associated with both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), as published in the journal Nature and reported in Bioscience Technology

Mutation triggers ALS and FTD brain damage. 
The researchers said that the altered C9orf72 gene, located on human chromosome 9, instigates RNA molecules to block critical pathways for protein transport. This causes a molecular traffic jam outside brain cell nuclei and affects their operations and survival. An experiment showed that a molecular therapy relieved the jam and restored molecular flow into the cell’s core.

According to Jeffrey Rothstein, M.D., Ph.D., a professor of neurology and director of the Brain Science Institute and the Robert Packard Center for ALS Research at the Johns Hopkins University School of Medicine, “The discovery several years ago of this mutation — the most common one linked to ALS and FTD — was really a game changer for the field because it wasn’t a typical genetic mutation. Now we have some information about what it is doing early on to damage brain and spinal cord cells.”

“The mutation, the most common of the known genetic risk factors for the diseases, is associated with 40 percent of inherited ALS cases, 25 percent of inherited FTD and around 10 percent of noninherited cases of each disease,” said the press release from Johns Hopkins. “Both diseases are characterized by degeneration of nerve cells over time. In the case of FTD, the damage causes problems with speech, understanding language and processing emotions. In ALS, the degeneration affects cells in the spinal cord as well as the brain, and patients gradually lose the ability to control their muscles.”

Rothstein added that researchers knew that the C9orf72 mutation, rather than changing one building block of DNA to another, caused an area of six DNA nucleotides to repeat hundreds of times. Because of the mutated DNA, the affected cells create long strands of repetitive RNA, genetic material normally responsible for transferring DNA’s genetic code outside the nuclei, to the apparatus that translates it into proteins.

Two years ago, Rothstein’s lab identified more than 400 proteins in the cell with which the repetitive RNA strands could interact directly. Now, along with the research group of Thomas Lloyd, M.D., Ph.D., an associate professor of neurology at Johns Hopkins, Rothstein’s team has found one of those proteins, RanGAP, to be critical to mediating the mutated RNA’s effect on cells.

According to Lloyd, “The key breakthrough came from using a fruit fly model of human ALS and FTD that allowed us to screen these 400 candidates for ones that block brain cell death in a living organism. This work identified RanGAP as a critical target of the C9orf72 repeats that could prevent brain cell death when its function was restored.”

When cells are healthy, RanGAP is a means of transporting molecules through nuclear pores that connect a cell’s cytoplasm and the nucleus. In their experiments with fly and human brain cells made from patients with the ALS-associated C9orf72 mutation, the researchers found that RanGAP is clumped up outside the nucleus. Proteins that rely on RanGAP for transportation into the nucleus cannot flow through the nuclear pores.

“The group had the data in human stem cells and a fly model, but we really wanted to know whether we could see this in the brains of patients,” said Rothstein. “So we went to our autopsy bank of human brain tissue and started looking.”

As the researchers looked at slices of brain tissue from patients with ALS and FTD, they found similar clumps of RanGAP and other proteins, including some crucial to neuron function, gathered outside of the brain cell nuclei. In experiments using the fly and human stem cells, the scientists inserted antisense oligonucleotides, pieces of RNA to bind to the repetitive RNA strands, to block them from interacting with the RanGAP protein. The clogged nuclear pores reopened, and critical proteins moved into the nucleus.

Rothstein is collaborating with Isis Pharmaceuticals to develop a drug to achieve the same for patients with ALS and FTD. While he believes that further studies are needed, he thinks his team has found a “good therapeutic target.”

 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 17, 2019
Neuroscience
NOV 17, 2019
Intelligence, Not Mindset, Predicts Learning Ability
New research has found that intelligence may play more of a role in a person’s ability to learn to play the piano than believing in oneself or having...
DEC 02, 2019
Drug Discovery & Development
DEC 02, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
DEC 29, 2019
Cell & Molecular Biology
DEC 29, 2019
How close are we to a simple blood test for Parkinson's Disease?
Parkinson’s Disease (PD) alters nerve cells in the brain that produce the neurotransmitter dopamine. Famously regarded as the “happiness”...
DEC 30, 2019
Genetics & Genomics
DEC 30, 2019
Chinese Scientists Implant Genes for Human Intelligence in Monkeys
Scientists from China and the US have implanted a human gene linked to intelligence in the genomes of macaque monkeys. The first experiment of its kind, th...
DEC 30, 2019
Neuroscience
DEC 30, 2019
Amyloid Plaques May Not Come First in Alzheimer's
It’s commonly thought that excessive build-up of amyloid plaques, destroying the connections between nerve cells, is the first sign of Alzheimer&rsqu...
JAN 14, 2020
Cannabis Sciences
JAN 14, 2020
New Links Between Cannabis, Anxiety, and Stress
A delicate balance of signaling in the endocannabinoid system could be responsible for anxiety symptoms as a result of stress. At least for mice. A new stu...
Loading Comments...